• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性出血性毛细血管扩张症、肝脏血管畸形和心脏后果。

Hereditary hemorrhagic telangiectasia, liver vascular malformations and cardiac consequences.

机构信息

Hospices Civils de Lyon, Service d'Explorations Cardiologiques, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.

出版信息

Eur J Intern Med. 2013 Apr;24(3):e35-9. doi: 10.1016/j.ejim.2012.12.013. Epub 2013 Jan 9.

DOI:10.1016/j.ejim.2012.12.013
PMID:23312966
Abstract

BACKGROUND

HHT patients with liver vascular malformations (VMs) may develop high-output cardiac failure requiring liver transplant in few cases.

OBJECTIVE

Our aim is to show that echocardiography is a good tool to evaluate the severity of hepatic vascular malformations in HHT and can improve medical management in HHT patients.

METHODS

The study is a cross-sectional study of cardiac parameters in HHT patients with dyspnea in a single referral center. All HHT patients with dyspnea, consecutively seen at HHT reference center in Lyon between May 2007 and November 2009 were included and had hepatic vascular Ultrasound and Echocardiography. Echocardiographic measures included cardiac output (CO) and index (CI), left ventricle (LV) filling pressures, and pulmonary artery pressure. Then, patients were classified in 4 groups according to the severity: group 1 (normal values), group 2 with isolated high CI, group 3 with high CI and increased LV-filling pressures and group 4 with increased LV-filling pressures and pulmonary hypertension.

RESULTS

Fifty-two HHT-patients were analyzed. Eight patients were in group 1, 25 in group 2, 6 in group 3 and 13 in group 4. Age, NYHA class dyspnea, edema, atrial fibrillation, hepatic artery diameter, and BNP (brain natriuretic peptide) levels significantly increased from groups 1 to 4 as well as left atrial area, and presence of mitral regurgitation. Patients with associated pulmonary VMs (n=11) did not show any clinical or echocardiographic differences.

CONCLUSION

Performing echocardiography in HHT patients with dyspnea allowed us to better understand the physiological processes of high-CO failure complicating liver vascular malformations and may improve follow-up of patients and treatment decisions.

摘要

背景

患有肝脏血管畸形(VM)的 HHT 患者在少数情况下可能会因高输出性心力衰竭而需要进行肝移植。

目的

我们旨在展示超声心动图是评估 HHT 中肝脏血管畸形严重程度的一种良好工具,并能改善 HHT 患者的治疗管理。

方法

这是在里昂的一个单一转诊中心对呼吸困难的 HHT 患者进行的一项心脏参数的横断面研究。所有在 2007 年 5 月至 2009 年 11 月期间连续在 HHT 参考中心就诊的呼吸困难的 HHT 患者均被纳入研究,并进行了肝脏血管超声和超声心动图检查。超声心动图检查包括心输出量(CO)和指数(CI)、左心室(LV)充盈压和肺动脉压。然后,根据严重程度将患者分为 4 组:第 1 组(正常值)、第 2 组(孤立性高 CI)、第 3 组(高 CI 和 LV 充盈压增加)和第 4 组(LV 充盈压增加和肺动脉高压)。

结果

分析了 52 名 HHT 患者。8 名患者为第 1 组,25 名患者为第 2 组,6 名患者为第 3 组,13 名患者为第 4 组。年龄、纽约心脏协会(NYHA)呼吸困难分级、水肿、心房颤动、肝总动脉直径和脑钠肽(BNP)水平从第 1 组到第 4 组逐渐增加,左心房面积和二尖瓣反流的存在也逐渐增加。伴有肺动静脉畸形(n=11)的患者在临床或超声心动图方面没有任何差异。

结论

对呼吸困难的 HHT 患者进行超声心动图检查,可以更好地了解肝脏血管畸形并发高 CO 衰竭的生理过程,并可能改善患者的随访和治疗决策。

相似文献

1
Hereditary hemorrhagic telangiectasia, liver vascular malformations and cardiac consequences.遗传性出血性毛细血管扩张症、肝脏血管畸形和心脏后果。
Eur J Intern Med. 2013 Apr;24(3):e35-9. doi: 10.1016/j.ejim.2012.12.013. Epub 2013 Jan 9.
2
Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study.遗传性出血性毛细血管扩张症患者肝移植术后严重肝累及的长期预后:单中心研究。
Liver Transpl. 2010 Mar;16(3):340-7. doi: 10.1002/lt.21990.
3
Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output.贝伐珠单抗治疗遗传性出血性毛细血管扩张症伴严重肝血管畸形和高心输出量患者。
JAMA. 2012 Mar 7;307(9):948-55. doi: 10.1001/jama.2012.250.
4
High prevalence of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症患者中肺动脉高压的高患病率。
Eur J Intern Med. 2013 Apr;24(3):e30-4. doi: 10.1016/j.ejim.2012.11.012. Epub 2012 Dec 13.
5
Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease).遗传性出血性毛细血管扩张症(伦杜-奥斯勒病)的肺血管表现
Respiration. 2007;74(4):361-78. doi: 10.1159/000103205.
6
Pulmonary gas exchange in hereditary hemorrhagic telangiectasia patients with liver arteriovenous malformations.遗传性出血性毛细血管扩张症伴肝动静脉畸形患者的肺气体交换。
Respir Res. 2019 Jul 4;20(1):137. doi: 10.1186/s12931-019-1106-y.
7
Liver involvement in hereditary hemorrhagic telangiectasia (HHT).遗传性出血性毛细血管扩张症(HHT)中的肝脏受累情况。
J Hepatol. 2007 Mar;46(3):499-507. doi: 10.1016/j.jhep.2006.12.008. Epub 2007 Jan 2.
8
Prevalence and nature of dyspnea in patients with hereditary hemorrhagic telangiectasia (HHT).遗传性出血性毛细血管扩张症(HHT)患者呼吸困难的患病率及性质
Respir Med. 2015 Jun;109(6):768-77. doi: 10.1016/j.rmed.2015.04.003. Epub 2015 Apr 15.
9
Subaortic Membranes in Patients With Hereditary Hemorrhagic Telangiectasia and Liver Vascular Malformations.遗传性出血性毛细血管扩张症和肝血管畸形患者的主动脉下膜。
J Am Heart Assoc. 2020 Oct 20;9(20):e016197. doi: 10.1161/JAHA.120.016197. Epub 2020 Oct 15.
10
Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry.遗传性出血性毛细血管扩张症的肝移植:欧洲肝脏移植登记处报告
Ann Surg. 2006 Dec;244(6):854-62; discussion 862-4. doi: 10.1097/01.sla.0000247258.35406.a4.

引用本文的文献

1
Hereditary hemorrhagic telangiectasia involving portal venous system: A case report and review of the literature.遗传性出血性毛细血管扩张累及门静脉系统:一例报告并文献复习
World J Gastrointest Surg. 2023 Oct 27;15(10):2367-2375. doi: 10.4240/wjgs.v15.i10.2367.
2
An Unusual Cause of Right Heart Dysfunction and High Output Heart Failure in a Young Woman.一名年轻女性右心功能不全和高输出量心力衰竭的罕见病因
J Cardiovasc Dev Dis. 2022 Nov 26;9(12):418. doi: 10.3390/jcdd9120418.
3
Obstetrical and neonatal complications in hereditary haemorrhagic telangiectasia: A retrospective study.
遗传性出血性毛细血管扩张症的产科和新生儿并发症:一项回顾性研究。
BJOG. 2023 Feb;130(3):303-311. doi: 10.1111/1471-0528.17303. Epub 2022 Oct 9.
4
Hereditary hemorrhagic telangiectasia (HHT): a practical guide to management.遗传性出血性毛细血管扩张症(HHT):管理实用指南。
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):469-477. doi: 10.1182/hematology.2021000281.
5
Subaortic Membranes in Patients With Hereditary Hemorrhagic Telangiectasia and Liver Vascular Malformations.遗传性出血性毛细血管扩张症和肝血管畸形患者的主动脉下膜。
J Am Heart Assoc. 2020 Oct 20;9(20):e016197. doi: 10.1161/JAHA.120.016197. Epub 2020 Oct 15.
6
Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia: Real-World Data from the Gemelli Hospital HHT Registry.遗传性出血性毛细血管扩张症的抗栓治疗:来自杰梅利医院遗传性出血性毛细血管扩张症登记处的真实世界数据。
J Clin Med. 2020 Jun 2;9(6):1699. doi: 10.3390/jcm9061699.
7
Hereditary hemorrhagic telangiectasia of liver: Pathophysiology with role of radiology in diagnosis and treatment.肝脏遗传性出血性毛细血管扩张症:病理生理学及放射学在诊断和治疗中的作用
Indian J Radiol Imaging. 2020 Jan-Mar;30(1):98-101. doi: 10.4103/ijri.IJRI_367_19. Epub 2020 Mar 30.
8
BMP10-mediated ALK1 signaling is continuously required for vascular development and maintenance.BMP10 介导的 ALK1 信号持续地对血管发育和维持是必需的。
Angiogenesis. 2020 May;23(2):203-220. doi: 10.1007/s10456-019-09701-0. Epub 2019 Dec 11.
9
Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症患者使用直接口服抗凝剂的安全性。
Orphanet J Rare Dis. 2019 Aug 28;14(1):210. doi: 10.1186/s13023-019-1179-1.
10
Different forms of pulmonary hypertension in a family with clinical and genetic evidence for hereditary hemorrhagic teleangectasia type 2.一个具有2型遗传性出血性毛细血管扩张症临床和遗传证据的家族中的不同形式肺动脉高压
Pulm Circ. 2018 Oct-Dec;8(4):2045894018782664. doi: 10.1177/2045894018782664. Epub 2018 May 25.